Rhinomed Ltd
ASX:RNO

Watchlist Manager
Rhinomed Ltd Logo
Rhinomed Ltd
ASX:RNO
Watchlist
Price: 0.04 AUD Market Closed
Market Cap: 11.3m AUD

Wall Street
Price Targets

RNO Price Targets Summary
Rhinomed Ltd

There are no price targets for RNO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Rhinomed Ltd Competitors:
Price Targets
600521
Zhejiang Huahai Pharmaceutical Co Ltd
26% Upside
CLBIO
Corline Biomedical AB
89% Upside
LPCN
Lipocine Inc
12% Downside
XERS
Xeris Biopharma Holdings Inc
55% Upside
RPRX
Royalty Pharma PLC
19% Upside
002603
Shijiazhuang Yiling Pharmaceutical Co Ltd
8% Upside
AUROPHARMA
Aurobindo Pharma Ltd
11% Upside
OMER
Omeros Corp
110% Upside

Revenue
Forecast

Revenue Estimate
Rhinomed Ltd

For the last 8 years the compound annual growth rate for Rhinomed Ltd's revenue is 41%. The projected CAGR for the next 7 years is -14%.

41%
Past Growth
-14%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Rhinomed Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Rhinomed Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RNO's stock price target?
Not Available

RNO doesn't have any price targets made by Wall Street professionals.

What is Rhinomed Ltd's Revenue forecast?
Projected CAGR
-14%

For the last 8 years the compound annual growth rate for Rhinomed Ltd's revenue is 41%. The projected CAGR for the next 7 years is -14%.

Back to Top